News

Teknova to Report First Quarter 2024 Financial Results on May 13, 2024

HOLLISTER, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, following the close of market.

04/29/2024

Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

HOLLISTER, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year ended December 31, 2023, on Monday, March 11, 2024, following the close of market.

02/21/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Alpha Teknova, Inc. (TKNO) a buy, sell, or hold?

Alpha Teknova, Inc. (TKNO) can sell. Click on Rating Page for detail.

What is Alpha Teknova, Inc.'s stock price?

The price of Alpha Teknova, Inc. (TKNO) is 1.9 and it was updated on 2024-05-05 07:00:44.

Is Alpha Teknova, Inc. (TKNO) overvalued or undervalued?

Currently Alpha Teknova, Inc. (TKNO) is in undervalued.

News

From:

To:

News
Alpha Teknova, Inc. (TKNO) Q3 2023 Earnings Call Transcript Alpha Teknova, Inc. (TKNO) Q3 2023 Earnings Call Transcript Sat, Nov. 11, 2023
Teknova to Report Third Quarter 2023 Financial Results on November 9, 2023 Teknova today announced that the Company will report its financial results for the third quarter on Thursday, November 9, 2023, following close of market. Thu, Oct. 26, 2023
Alpha Teknova, Inc. (TKNO) Q2 2023 Earnings Call Transcript Alpha Teknova, Inc. (NASDAQ:TKNO ) Q2 2023 Earnings Conference Call August 10, 2023 5:30 PM ET Company Participants Sara Michelmore - MacDougall Advisors Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Steven Mah - TD Cowen Matt Larew - William. Blair Paul Knight - KeyBanc Mark Massaro - BTIG Jacob Johnson - Stephens Operator Good day, and welcome to Teknova's Second Quarter 2023 Financial Results Conference Call. Sun, Aug. 13, 2023
Teknova to Report Second Quarter 2023 Financial Results on August 10, 2023 HOLLISTER, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2023, on Thursday, August 10, 2023, following the close of market. Wed, Jul. 26, 2023
Teknova to Participate in Upcoming Investor Conference HOLLISTER, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will present and host individual and small group meetings at the following upcoming investor conference: Thu, May. 25, 2023

Transcripts

Transcipts Data
Alpha Teknova, Inc. (TKNO) on Q4 2023 Results - Earnings Call Transcript SA Transcripts Tue, Mar. 12, 2024
Alpha Teknova, Inc. (TKNO) on Q3 2023 Results - Earnings Call Transcript SA Transcripts Sat, Nov. 11, 2023
Alpha Teknova, Inc. (TKNO) on Q2 2023 Results - Earnings Call Transcript SA Transcripts Sun, Aug. 13, 2023
Alpha Teknova, Inc. (TKNO) on Q1 2023 Results - Earnings Call Transcript SA Transcripts Sat, May. 13, 2023
Alpha Teknova, Inc. (TKNO) on Q4 2022 Results - Earnings Call Transcript SA Transcripts Wed, Mar. 15, 2023
Alpha Teknova, Inc. (TKNO) on Q3 2022 Results - Earnings Call Transcript SA Transcripts Sun, Nov. 13, 2022
Alpha Teknova, Inc. (TKNO) on Q2 2022 Results - Earnings Call Transcript SA Transcripts Wed, Aug. 10, 2022
Alpha Teknova, Inc. (TKNO) on Q1 2022 Results - Earnings Call Transcript SA Transcripts Sun, May. 15, 2022
Alpha Teknova, Inc. (TKNO) on Q4 2021 Results - Earnings Call Transcript SA Transcripts Tue, Mar. 15, 2022
Alpha Teknova, Inc. (TKNO) on Q3 2021 Results - Earnings Call Transcript SA Transcripts Fri, Nov. 12, 2021

SEC Filings

SEC Filings
Alpha Teknova, Inc. (TKNO) - DEFA14A SEC Filings 04/29/2024
Alpha Teknova, Inc. (TKNO) - DEF 14A SEC Filings 04/29/2024
Alpha Teknova, Inc. (TKNO) - ARS SEC Filings 04/29/2024
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 04/02/2024
Alpha Teknova, Inc. (TKNO) - S-8 SEC Filings 03/27/2024
Alpha Teknova, Inc. (TKNO) - 10-K - Current report SEC Filings 03/27/2024
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 03/11/2024
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 02/27/2024
Alpha Teknova, Inc. (TKNO) - DEF 14C SEC Filings 02/22/2024
Alpha Teknova, Inc. (TKNO) - SC 13G/A SEC Filings 02/14/2024
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 02/06/2024
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 02/02/2024
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 01/16/2024
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 12/01/2023
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 11/15/2023
Alpha Teknova, Inc. (TKNO) - 10-Q - Quarterly Report SEC Filings 11/13/2023
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 11/09/2023
Alpha Teknova, Inc. (TKNO) - 424B3 SEC Filings 11/09/2023
Alpha Teknova, Inc. (TKNO) - EFFECT SEC Filings 11/08/2023
Alpha Teknova, Inc. (TKNO) - S-1 SEC Filings 10/25/2023
Alpha Teknova, Inc. (TKNO) - SC 13G/A SEC Filings 10/06/2023
Alpha Teknova, Inc. (TKNO) - D SEC Filings 09/27/2023
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 09/21/2023
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 09/19/2023
Alpha Teknova, Inc. (TKNO) - 424B5 SEC Filings 09/19/2023
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 09/05/2023
Alpha Teknova, Inc. (TKNO) - 3 SEC Filings 08/31/2023
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 08/14/2023
Alpha Teknova, Inc. (TKNO) - 10-Q - Quarterly Report SEC Filings 08/11/2023
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 08/10/2023
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 07/10/2023
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 06/20/2023
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 06/14/2023
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 05/31/2023
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 05/17/2023
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 05/16/2023
Alpha Teknova, Inc. (TKNO) - 10-Q - Quarterly Report SEC Filings 05/11/2023
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 05/10/2023
Alpha Teknova, Inc. (TKNO) - DEFA14A SEC Filings 04/28/2023
Alpha Teknova, Inc. (TKNO) - DEF 14A SEC Filings 04/28/2023
Alpha Teknova, Inc. (TKNO) - ARS SEC Filings 04/28/2023
Alpha Teknova, Inc. (TKNO) - 424B5 SEC Filings 03/30/2023
Alpha Teknova, Inc. (TKNO) - 10-K - Current report SEC Filings 03/30/2023
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 03/15/2023
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 03/13/2023
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 03/01/2023
Alpha Teknova, Inc. (TKNO) - S-8 SEC Filings 01/30/2023
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 11/17/2022
Alpha Teknova, Inc. (TKNO) - 10-Q - Quarterly Report SEC Filings 11/14/2022
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 11/09/2022
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 10/04/2022
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 09/02/2022
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 08/25/2022
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 08/15/2022
Alpha Teknova, Inc. (TKNO) - 10-Q - Quarterly Report SEC Filings 08/11/2022
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 08/10/2022
Alpha Teknova, Inc. (TKNO) - EFFECT SEC Filings 07/13/2022
Alpha Teknova, Inc. (TKNO) - EFFECT SEC Filings 07/13/2022
Alpha Teknova, Inc. (TKNO) - UPLOAD SEC Filings 07/08/2022
Alpha Teknova, Inc. (TKNO) - CORRESP SEC Filings 07/08/2022
Alpha Teknova, Inc. (TKNO) - S-3 SEC Filings 07/01/2022
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 06/03/2022
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 06/03/2022
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 05/23/2022
Alpha Teknova, Inc. (TKNO) - 10-Q - Quarterly Report SEC Filings 05/12/2022
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 05/11/2022
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 05/10/2022
Alpha Teknova, Inc. (TKNO) - DEF 14A SEC Filings 04/28/2022
Alpha Teknova, Inc. (TKNO) - 10-K - Current report SEC Filings 03/18/2022
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 03/15/2022
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 02/17/2022
Alpha Teknova, Inc. (TKNO) - SC 13G SEC Filings 02/14/2022
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 02/07/2022
Alpha Teknova, Inc. (TKNO) - S-8 SEC Filings 01/27/2022
Alpha Teknova, Inc. (TKNO) - 4/A SEC Filings 11/24/2021
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 11/23/2021
Alpha Teknova, Inc. (TKNO) - 3 SEC Filings 11/23/2021
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 11/15/2021
Alpha Teknova, Inc. (TKNO) - 10-Q - Quarterly Report SEC Filings 11/12/2021
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 11/10/2021
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 09/16/2021
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 09/10/2021
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 08/26/2021
Alpha Teknova, Inc. (TKNO) - 10-Q - Quarterly Report SEC Filings 08/13/2021
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 08/11/2021
Alpha Teknova, Inc. (TKNO) - S-8 SEC Filings 06/29/2021
Alpha Teknova, Inc. (TKNO) - 8-K - Current report SEC Filings 06/29/2021
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 06/29/2021
Alpha Teknova, Inc. (TKNO) - 4 SEC Filings 06/28/2021
Alpha Teknova, Inc. (TKNO) - EFFECT SEC Filings 06/25/2021
Alpha Teknova, Inc. (TKNO) - 424B4 SEC Filings 06/25/2021
Alpha Teknova, Inc. (TKNO) - EFFECT SEC Filings 06/24/2021
Alpha Teknova, Inc. (TKNO) - SEC STAFF LETTER SEC Filings 06/24/2021
Alpha Teknova, Inc. (TKNO) - S-1MEF SEC Filings 06/24/2021
Alpha Teknova, Inc. (TKNO) - CERT SEC Filings 06/24/2021
Alpha Teknova, Inc. (TKNO) - 8-A12B SEC Filings 06/24/2021
Alpha Teknova, Inc. (TKNO) - 3 SEC Filings 06/24/2021
Alpha Teknova, Inc. (TKNO) - CORRESP SEC Filings 06/23/2021
Alpha Teknova, Inc. (TKNO) - S-1/A SEC Filings 06/21/2021
Alpha Teknova, Inc. (TKNO) - CORRESP SEC Filings 06/21/2021
Alpha Teknova, Inc. (TKNO) - SEC STAFF LETTER SEC Filings 06/08/2021
Alpha Teknova, Inc. (TKNO) - S-1 SEC Filings 06/04/2021
Alpha Teknova, Inc. (TKNO) - CORRESP SEC Filings 06/04/2021
Alpha Teknova, Inc. (TKNO) - UPLOAD SEC Filings 05/27/2021
Alpha Teknova, Inc. (TKNO) - DRSLTR SEC Filings 05/14/2021
Alpha Teknova, Inc. (TKNO) - DRS/A SEC Filings 05/14/2021
Alpha Teknova, Inc. (TKNO) - UPLOAD SEC Filings 05/04/2021
Alpha Teknova, Inc. (TKNO) - DRS SEC Filings 04/05/2021

Press Releases

StockPrice Release
Teknova to report first quarter 2024 financial results on may 13, 2024 04/29/2024
Teknova reports fourth quarter and full year 2023 financial results 03/11/2024
Teknova to report fourth quarter and full year 2023 financial results on march 11, 2024 02/21/2024
Teknova reports third quarter 2023 financial results 11/09/2023
Teknova to report third quarter 2023 financial results on november 9, 2023 10/26/2023
Teknova launches latest proprietary aav-tek™ product and end-to-end plasmid workflow solutions to streamline therapeutic process development 09/27/2023
Teknova announces closing of $22.9 million concurrent registered direct offering and private placement and amends credit facility 09/19/2023
Teknova reports second quarter 2023 financial results 08/10/2023
Teknova announces opening of new gmp-certified facility, increasing manufacturing capacity for custom, high-quality life sciences reagents 08/09/2023
Teknova to report second quarter 2023 financial results on august 10, 2023 07/26/2023
Teknova expands proprietary aav-tek™ solutions product line to deliver end-to-end solutions for gene therapy process development 07/11/2023
Teknova to participate in upcoming investor conference 05/25/2023
Teknova to present data on novel products to accelerate the development of aav therapies at asgct 2023 annual meeting 05/10/2023
Teknova to report first quarter 2023 financial results on may 10, 2023 04/26/2023
Teknova and sartorius bia separations announce collaboration to address critical pain point in gene therapy process development 03/15/2023
Teknova to participate in upcoming investor conferences 02/10/2023
Teknova to participate in upcoming investor conferences 11/03/2022
Teknova to report third quarter 2022 financial results on november 9, 2022 10/26/2022
Teknova to participate in upcoming investor conference 08/31/2022
Teknova to report second quarter 2022 financial results on august 10, 2022 08/01/2022
Teknova to report first quarter 2022 financial results on may 11, 2022 05/04/2022
Teknova to report fourth quarter and full year 2021 financial results on march 15, 2022 03/02/2022
Teknova announces preliminary revenue of $10.0 to $10.1 million for the fourth quarter 2021 02/28/2022
Teknova to participate in upcoming investor conference 02/14/2022
Teknova to join the nasdaq biotechnology index 12/15/2021
Teknova to participate in upcoming investor conferences 11/16/2021
Teknova reports second quarter 2021 financial results 08/11/2021
Teknova announces closing of initial public offering and full exercise of the underwriters' option to purchase additional shares 06/29/2021
Teknova announces pricing of its upsized initial public offering 06/24/2021

More Headlines

News
Alpha Teknova, Inc. (TKNO) Q1 2023 Earnings Call Transcript Alpha Teknova, Inc. (NASDAQ:TKNO ) Q1 2023 Earnings Conference Call May 10, 2023 5:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Jacob Johnson - Stephens Madeline Mollman - William Blair Steven Mah - TD Cowen Operator Good day, and welcome to the Teknova First Quarter 2023 Financial Results Call. [Operator Instructions] Please be advised that today's conference is being recorded. 05/13/2023
Teknova to Present Data on Novel Products to Accelerate the Development of AAV Therapies at ASGCT 2023 Annual Meeting Company will share their latest findings for custom product innovations aimed at addressing key gene therapy bioprocessing bottlenecks Company will share their latest findings for custom product innovations aimed at addressing key gene therapy bioprocessing bottlenecks 05/10/2023
Teknova to Report First Quarter 2023 Financial Results on May 10, 2023 HOLLISTER, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2023, on Wednesday, May 10, 2023, following the close of market. 04/26/2023
Down -48.43% in 4 Weeks, Here's Why You Should You Buy the Dip in Alpha Teknova (TKNO) Alpha Teknova (TKNO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. 04/07/2023
Alpha Teknova, Inc. (TKNO) Q4 2022 Earnings Call Transcript Alpha Teknova, Inc. (NASDAQ:TKNO ) Q4 2022 Results Conference Call March 15, 2023 5:00 PM ET Company Participants Jen Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matt Lowell - Chief Financial Officer Conference Call Participants Joseph Flanagan - Cowen Matt Larew - William Blair Hannah Hefley - Stephens Operator Thank you for standing by, and welcome to Teknova's Fourth Quarter and Full Year 2022 Financial Results Call. At this time, all participants are in a listen-only mode. 03/15/2023
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Cara Therapeutics (NASDAQ:CARA), AdaptHealth (NASDAQ:AHCO) The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 03/14/2023
Teknova to Participate in Upcoming Investor Conferences HOLLISTER, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conferences: 02/10/2023
Alpha Teknova, Inc. (TKNO) Q3 2022 Earnings Call Transcript Alpha Teknova, Inc. (NASDAQ:TKNO ) Q3 2022 Earnings Conference Call November 21, 2022 4:30 PM ET Company Participants Jennifer Henry - Senior Vice President of Marketing Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Operator Good day, and thank you for standing by. Welcome to the Teknova Third Quarter 2022 Financial Results Conference Call. 11/13/2022
Teknova to Participate in Upcoming Investor Conferences HOLLISTER, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, research, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conferences: 11/03/2022
Teknova to Report Third Quarter 2022 Financial Results on November 9, 2022 HOLLISTER, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2022, on Wednesday, November 9, 2022, following the close of market. 10/26/2022
Teknova to Participate in Upcoming Investor Conference HOLLISTER, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conference. 08/31/2022
Alpha Teknova, Inc. (TKNO) CEO Stephen Gunstream on Q2 2022 Results - Earnings Call Transcript Alpha Teknova, Inc. (NASDAQ:TKNO ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Sara Michelmore - Head of Investor Relations, MacDougall Advisors Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Stephanie Yan - Cowen Matt Larew - William Blair Jake Johnson - Stephens Operator Good day, and thank you for standing by. Welcome to the Teknova Second Quarter 2022 Financial Results Conference Call. 08/10/2022
Teknova to Report Second Quarter 2022 Financial Results on August 10, 2022 HOLLISTER, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the second quarter ended June 30, 2022, on Wednesday, August 10, 2022, following the close of market. 08/01/2022
Alpha Teknova, Inc. (TKNO) CEO Stephen Gunstream on Q1 2022 Results - Earnings Call Transcript Alpha Teknova, Inc. (NASDAQ:TKNO ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Sara Michelmore - Head of Investor Relations, MacDougall Advisors Stephen Gunstream - President & Chief Executive Officer Matthew Lowell - Chief Financial Officer Conference Call Participants Matthew Larew - William Blair Stephanie Yan - Cowen and Company Jacob Johnson - Stephens, Inc. Operator Good day, and thank you for standing by. Welcome to the Teknova First Quarter 2022 Financial Results Conference Call. 05/15/2022
Teknova to Report First Quarter 2022 Financial Results on May 11, 2022 HOLLISTER, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the first quarter ended March 31, 2022, on Wednesday, May 11, 2022, following the close of market. 05/04/2022
Alpha Teknova's (TKNO) CEO Stephen Gunstream on Q4 2021 Results - Earnings Call Transcript Alpha Teknova's (TKNO) CEO Stephen Gunstream on Q4 2021 Results - Earnings Call Transcript 03/15/2022
Teknova to Report Fourth Quarter and Full Year 2021 Financial Results on March 15, 2022 HOLLISTER, Calif., March 02, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the discovery, development, and commercialization of drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the fourth quarter and full year 2021 on Tuesday, March 15, 2022, following the close of market. 03/02/2022
Teknova to Participate in Upcoming Investor Conference HOLLISTER, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical products, including drug therapies, novel vaccines, and molecular diagnostics, today announced that the Company will participate in the following upcoming investor conference. 02/14/2022
Teknova to Participate in Upcoming Investor Conferences HOLLISTER, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical products, including drug therapies, novel vaccines, and molecular diagnostics, today announced that the company will participate in the following upcoming investor conferences. 11/16/2021
Alpha Teknova, Inc. (TKNO) CEO Stephen Gunstream on Q3 2021 Results - Earnings Call Transcript Alpha Teknova, Inc. (TKNO) CEO Stephen Gunstream on Q3 2021 Results - Earnings Call Transcript 11/12/2021
Teknova Reports Second Quarter 2021 Financial Results —$8.3 million in total revenue, up 38% year-over-year— 08/11/2021
Teknova Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares HOLLISTER, Calif., June 29, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical products including drug therapies, novel vaccines, and molecular diagnostics, today announced that on June 29, 2021, it closed its previously announced initial public offering of 6,900,000 shares of its common stock, at a price to the public of $16.00 per share. The closing included 900,000 shares sold upon full exercise of the underwriters' option to purchase additional shares of common stock in the offering. All of the shares of common stock were offered and sold by Teknova. 06/29/2021
7 Companies Go Public Today. What Investors Need to Know. Acurx Pharmaceuticals, Alpha Teknova, Elevation Oncology, GH Research, Graphite Bio, and MissFresh are listed on the Nasdaq. Mister Car Wash is trading the New York Stock Exchange. 06/25/2021
Teknova Announces Pricing of its Upsized Initial Public Offering HOLLISTER, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical products including drug therapies, novel vaccines, and molecular diagnostics, today announced the pricing of its upsized initial public offering of 6,000,000 shares of its common stock at a price to the public of $16.00 per share. Additionally, Teknova has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares of common stock are being offered and sold by Teknova. 06/24/2021

Unlock

TKNO Ratings Summary

TKNO Quant Ranking